Exane Derivatives Cerence Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Cerence Inc. stock. As of the latest transaction made, Exane Derivatives holds 31 shares of CRNC stock, worth $386. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31
Previous 1,550
98.0%
Holding current value
$386
Previous $55,000
100.0%
% of portfolio
0.0%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding CRNC
# of Institutions
187Shares Held
33.5MCall Options Held
301KPut Options Held
795K-
American Capital Management Inc New York, NY3.92MShares$48.8 Million0.41% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$41.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.11MShares$38.8 Million0.0% of portfolio
-
Paradigm Capital Management Inc1.75MShares$21.8 Million0.25% of portfolio
-
Cooper Creek Partners Management LLC New York, NY1.62MShares$20.1 Million0.14% of portfolio
About Cerence Inc.
- Ticker CRNC
- Exchange NASDAQ
- Sector Technology
- Industry Software—Application
- Shares Outstandng 39,313,000
- Market Cap $490M
- Description
- Cerence Inc. provides AI powered virtual assistants for the mobility/transportation market worldwide. The company offers edge software components; cloud-connected components and related toolkits and applications; and virtual assistant coexistence and professional services. It also provides conversational artificial intelligence-based solutions, ...